array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Gcp Applied Technologies Inc."
["slug"]=>
string(37) "07e15-us-gcp-applied-technologies-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/49fe1b46-34d6-43fa-9b25-298bdc9cc2a4"
["description"]=>
string(499) "GCP is a leading global provider of construction products that include high-performance specialty construction chemicals and building materials. GCP partners with producers, contractors, designers and engineers to achieve performance and sustainability goals. The company has a legacy of first to market and award-winning solutions that have been used to build some of the world’s most renowned structures. GCP is focused on continuous improvement for its customers, end-users and the environment."
["address_street"]=>
string(18) "2325 Lakeview Pkwy"
["address_place"]=>
string(10) "Alpharetta"
["address_region"]=>
string(7) "Georgia"
["founding_date"]=>
string(10) "2015-02-28"
["website_domain"]=>
string(9) "gcpat.com"
["website_url"]=>
string(17) "https://gcpat.com"
["industry_codes"]=>
array(2) {
[0]=>
string(56) "Industrial Inorganic Chemicals, Not Elsewhere Classified"
[1]=>
string(61) "Chemicals and Chemical Preparations, Not Elsewhere Classified"
}
["employee_count"]=>
int(1800)
["article_count"]=>
int(213)
}
["articles"]=>
array(4) {
[0]=>
array(7) {
["title_en"]=>
string(62) "Clinical Microbiomics expanding with €10M million investment"
["snippet_en"]=>
string(123) "Danish microbiome research company Clinical Microbiomics A/S has received €10 million in funding from Seventure Partners."
["url"]=>
string(69) "https://www.labiotech.eu/trends-news/clinical-microbiomics-expanding/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/25f5d467-1a8e-4a27-ac03-f4c1c260ab78"
["source"]=>
string(12) "labiotech.eu"
["publication_date"]=>
string(10) "2022-10-11"
["categories"]=>
array(4) {
[0]=>
string(18) "General Investment"
[1]=>
string(16) "Customer Welfare"
[2]=>
string(17) "Academic Research"
[3]=>
string(19) "Investment Requests"
}
}
[1]=>
array(7) {
["title_en"]=>
string(101) "ECONOMIC DEVELOPMENT NEWS: GCP Applied Technologies Opens Research & Development Center In Wilmington"
["snippet_en"]=>
string(85) "GCP Applied Technologies is leasing nearly 40,000 of lab space at 100 Research Drive."
["url"]=>
string(112) "https://wilmingtonapple.com/2021/12/18/gcp-applied-technologies-opens-research-development-center-in-wilmington/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/389dfb4c-724e-44f8-8dfb-9c4452c75ba8"
["source"]=>
string(19) "wilmingtonapple.com"
["publication_date"]=>
string(10) "2021-12-18"
["categories"]=>
array(5) {
[0]=>
string(5) "R & D"
[1]=>
string(13) "Press Release"
[2]=>
string(17) "Academic Research"
[3]=>
string(23) "Real estate development"
[4]=>
string(7) "Opening"
}
}
[2]=>
array(7) {
["title_en"]=>
string(96) "PAREXEL Collaborates with Eli Lilly and Company to Develop China’s Clinical Research Workforce"
["snippet_en"]=>
string(137) "PAREXEL announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development program in China."
["url"]=>
string(159) "https://www.businesswire.com/news/home/20181205005144/en/PAREXEL-Collaborates-with-Eli-Lilly-and-Company-to-Develop-China%E2%80%99s-Clinical-Research-Workforce"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ba266664-e4b7-4afe-9aef-c2ce5ff2ba42"
["source"]=>
string(16) "businesswire.com"
["publication_date"]=>
string(10) "2018-12-05"
["categories"]=>
array(4) {
[0]=>
string(14) "Product Launch"
[1]=>
string(5) "R & D"
[2]=>
string(17) "Academic Research"
[3]=>
string(13) "Collaboration"
}
}
[3]=>
array(7) {
["title_en"]=>
string(165) "New FDA Guidance for Industry: Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring - Implications for Sponsors, CROs, Investigators and IRBs"
["snippet_en"]=>
string(293) "It’s no secret that ROI in clinical research has been abysmal for years. This poor ROI has forced massive changes in pharma product development investment decisions and organizational re-structuring. Some have pointed to the increasingly burdensome oversight mechanism in every facet of drug"
["url"]=>
string(46) "https://xtalks.com/webinars/xto486irbservices/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/50cd74ac-fda6-4518-8df8-c36fcfd3b63b"
["source"]=>
string(10) "xtalks.com"
["publication_date"]=>
string(10) "2017-02-03"
["categories"]=>
array(1) {
[0]=>
string(17) "Academic Research"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(17)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(13)
}
[2]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(12)
}
[3]=>
array(2) {
["name"]=>
string(18) "Activist Investors"
["count"]=>
int(7)
}
[4]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(6)
}
[5]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(6)
}
[6]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(5)
}
[7]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(5)
}
[8]=>
array(2) {
["name"]=>
string(13) "GHG Emissions"
["count"]=>
int(4)
}
[9]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(4)
}
[10]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(4)
}
[11]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(4)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(4)
}
[13]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(4)
}
[14]=>
array(2) {
["name"]=>
string(19) "Green & Responsible"
["count"]=>
int(4)
}
[15]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(3)
}
[16]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(3)
}
[17]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(3)
}
[18]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(3)
}
[19]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(3)
}
[20]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(3)
}
[21]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(2)
}
[22]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(2)
}
[23]=>
array(2) {
["name"]=>
string(11) "Sponsorship"
["count"]=>
int(2)
}
[24]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(2)
}
[25]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(2)
}
[26]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(2)
}
[27]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(2)
}
[28]=>
array(2) {
["name"]=>
string(33) "Materials Sourcing and Efficiency"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(19) "Under Investigation"
["count"]=>
int(2)
}
}
}
07e15-us-gcp-applied-technologies-inc
Gcp Applied Technologies Inc.
Location
Georgia
Founded
2015-02-28
Website
https://gcpat.com
Articles
213 Articles
Category
Industrial Inorganic Chemicals, Not Elsewhere Classified
Chemicals and Chemical Preparations, Not Elsewhere Classified
Description
GCP is a leading global provider of construction products that include high-performance specialty construction chemicals and building materials. GCP partners with producers, contractors, designers and engineers to achieve performance and sustainability goals. The company has a legacy of first to market and award-winning solutions that have been used to build some of the world’s most renowned structures. GCP is focused on continuous improvement for its customers, end-users and the environment.
It’s no secret that ROI in clinical research has been abysmal for years. This poor ROI has forced massive changes in pharma product development investment decisions and organizational re-structuring. Some have pointed to the increasingly burdensome oversight mechanism in every facet of drug
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
